scholarly journals The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders

2019 ◽  
Vol 326 ◽  
pp. 14-18 ◽  
Author(s):  
Paul Maddison ◽  
Maarten J. Titulaer ◽  
Jan J. Verschuuren ◽  
Paul Gozzard ◽  
Bethan Lang ◽  
...  
Keyword(s):  
Neurological Disorders ◽  
Cancer Prediction ◽  
Paraneoplastic Neurological Disorders

1600 The utility of SOX antibodies for cancer prediction in patients with paraneoplastic neurological disorders

2012 ◽  
Vol 83 (3) ◽  
pp. e1.135-e1
Author(s):  
P Maddison ◽  
M J Titulaer ◽  
J J G Verschuuren ◽  
P Gozzard ◽  
B Lang ◽  
...  
Keyword(s):  
Neurological Disorders ◽  
Cancer Prediction ◽  
Paraneoplastic Neurological Disorders

Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders

1999 ◽  
Vol 46 (5) ◽  
pp. 774-777 ◽  
Author(s):  
Albert Saiz ◽  
Francesc Graus ◽  
Josep Dalmau ◽  
Alex Pifarr� ◽  
Concepci� Mar�n ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Neurological Disorders ◽  
Brain Protein ◽  
Paraneoplastic Neurological Disorders

scholarly journals Immunomodulatory treatment trial for paraneoplastic neurological disorders

2004 ◽  
Vol 6 (1) ◽  
pp. 55-62 ◽  
Author(s):  
Steven Vernino ◽  
Brian Patrick O'Neill ◽  
Randolph S. Marks ◽  
Judith R. O'Fallon ◽  
David W. Kimmel
Keyword(s):  
Neurological Disorders ◽  
Treatment Trial ◽  
Immunomodulatory Treatment ◽  
Paraneoplastic Neurological Disorders

scholarly journals Paraneoplastic neurological syndromes: clinical presentations and management

2021 ◽  
Vol 14 ◽  
pp. 175628642098532
Author(s):  
Michelle F. Devine ◽  
Naga Kothapalli ◽  
Mahmoud Elkhooly ◽  
Divyanshu Dubey
Keyword(s):  
Patient Outcomes ◽  
Neurological Disorders ◽  
Immune Checkpoint Inhibitor ◽  
Checkpoint Inhibitor ◽  
Management Strategies ◽  
Paraneoplastic Neurological Syndrome ◽  
Paraneoplastic Neurological Syndromes ◽  
Onconeural Antibodies ◽  
Clinical Presentations ◽  
Paraneoplastic Neurological Disorders

We provide an overview of the varied presentations of paraneoplastic neurological syndromes. We also review the onconeural antibodies and their particular oncological and neurological associations. Recognition of these syndromes and their oncological associations is crucial, as early diagnosis and management has been associated with better patient outcomes. Specific management strategies and prognosis vary widely depending on the underlying etiology. An understanding of the relevant clinical details, imaging findings, and other diagnostic information can help tailor treatment approaches. We provide an outline of the diagnostic evaluation and treatment of various paraneoplastic neurological disorders, presenting with central and/or peripheral nervous system involvement. We briefly discuss neurologic immune checkpoint inhibitor-related adverse events, which can occasionally present with paraneoplastic neurological syndrome phenotypes.

Sign in / Sign up

Export Citation Format

Share Document